UNIMED, TN0007720014

UNIMED stock gained 1.27 percent on October 7

Published on 10/08/2026 at 00:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

UNIMED stock carried a TND 282.0 million market value on October 7, 2026. Q2 2026 revenue reached TND 68.281 million, down 6.0 percent year over year.

UNIMED, TN0007720014, Illustration mit AI erstellt.

UNIMED (ISIN TN0007720014) stock stood at TND 8.800 on the Bourse de Tunis on October 7, 2026, up 1.27 percent for the session. The next dated checkpoint is October 20, 2026, the legal deadline for Q3 2026 activity indicators, according to Mizen.

Q2 revenue fell 6.0 percent

Mizen reports Q2 2026 revenue of TND 68.281 million, down 6.0 percent from Q2 2025. Q1 2026 revenue was TND 30.941 million, down 7.0 percent year over year.

The two quarterly comparisons point to a revenue trend that remains weaker than the prior-year base. For investors, the October reporting deadline matters because it can show whether the decline narrowed during the third quarter.

Generic medicines drive the business

UNIMED says it develops, manufactures and sells generic medicines across Tunisia, Africa, Asia and Europe. Its product portfolio includes ophthalmic and ear, nose and throat solutions, infusion products, liquid injectables and powder injectables, according to the company website at UNIMED.

The company was founded in 1989 and also manufactures medicines for third-party laboratories. That mix gives the October activity report importance beyond the headline revenue figure because it can indicate whether branded and contract manufacturing demand moved in the same direction.

Analyst target points higher

Investing.com lists one analyst rating UNIMED Sell, with a 12-month average target of TND 10.60 and high and low targets both at TND 10.60. The target lies 20.45 percent above the TND 8.800 market price.

The consensus is therefore a counterweight to the recent price gain. It combines a higher numerical target with a negative rating label, leaving the October operating figures as the next concrete test for the valuation.

UNIMED stock stays below its yearly high

UNIMED stock has a 52-week range of TND 7.960 to TND 10.950 as of October 7, 2026. The TND 8.800 price is TND 2.150 below the yearly high, while the market capitalization stands at TND 282.0 million.